EsoGuard: Clinical Trials

4 trials of EsoGuard, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Recruiting 1

Follow EsoGuard: new trials by email Literature Review of EsoGuard trials Research Report on EsoGuard

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
EsoCheck, EsoGuard - Barrett Esophagus, Gastroesophageal Reflux
Not applicableRecruitingCase Comprehensive Cancer Center8002025-03-102026-09-15
Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype
EsoGuard - Barrett Esophagus, Anorexia Nervosa, Binge Eating/Purging Type
RecruitingDenver Health and Hospital Authority252024-11-122025-12-10
CLUE: CLinical Utility Study of EsoGuard
EsoGuard - Barrett Esophagus, Barretts Esophagus With Dysplasia
Not applicableCompletedLucid Diagnostics, Inc.5662023-02-232025-06-27
Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE
EsoGuard - Barrett Esophagus, Esophageal Adenocarcinoma
Not applicableCompletedLucid Diagnostics, Inc.1452020-02-282023-01-25

Conditions studied

Adenocarcinoma Of Esophagus (4)  ·  Barrett Esophagus (4)  ·  Anorexia Nervosa (1)  ·  Bulimia (1)  ·  Feeding and Eating Disorders (1)  ·  Gastroesophageal Reflux (1)  ·  Rumination Syndrome (1)  ·  Vomiting (1)

Sponsors

Lucid Diagnostics, Inc. (2)  ·  Case Comprehensive Cancer Center (1)  ·  Denver Health and Hospital Authority (1)

Countries

United States (4)  ·  Spain (1)

Top investigators

Allison Nitsch, MD (1)  ·  Amitabh Chak, MD (1)  ·  Gisella Lopez (1)  ·  Michelle McDermott (1)

Results publications

PMID 39588974